Low-dose methotrexate treatment is associated with increased total cholesterol and HDL-cholesterol in blood: A pilot study

Nutritional Sciences Journal

Volumn 35, Issue 4, 2010, Pages 157-164

  Chih, Hui Min ^a,b   Chang, Hsin Yueh ^a   Chen, Der Yuan ^b   Lan, Jung Lian ^b   Chiang, En Pei Isabel ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular risk; Foam cell; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; Methotrexate; Rheumatoid arthritis

Indexed keywords

ABC TRANSPORTER A1; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; LOW DRUG DOSE; PILOT STUDY; RHEUMATOID ARTHRITIS; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84863236847     PISSN: 10116958     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ideguchi H, Ohno S, Ishigatsubo Y. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis. J Clin Rheumatol. 2007;13:73-8. (Pubitemid 46597669)
2. Kawai S. Current drug therapy for rheumatoid arthritis. J Orthop Sci. 2003;8:259-63. (Pubitemid 36460527)
3. Nagaoka S, Nakamura M, Senuma A, Sekiguchi A. A clinical trial of low dose methotrexate therapy in patients with rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28:389-97.
4. Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991;18:188-94.
5. Durrington P. Dyslipidaemia. Lancet. 2003;362:717-31.
6. Miggiano GA, Gagliardi L. Diet, nutrition and rheumatoid arthritis. Clin Ther. 2005;156:115-23. (Pubitemid 43379046)
7. Braun J, Rau R. An update on methotrexate. Curr Opin Rheumatol. 2009;21:216-23.
8. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60 - more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009;11:R110.
9. Caporall R, Caprioli M, Bobbio-Pallavicini F, Montecucco C. DMARDS and infections in rheumatoid arthritis. Autoimmun Rev. 2008;8:139-43.
10. Lin G, Oram JF. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis. 2000;149:359-70. (Pubitemid 30145546)
11. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol. 1997;24(3):445-51. (Pubitemid 27153406)
12. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem. 1957;226:497-509.
13. Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10:R17.
14. Reiss AB, Carsons SE, Anwar K, et al. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis Rheum. 2008;58:3675-83.
15. Chan ES, Zhang H, Fernandez P, et al. Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk. Arthritis Res Ther. 2007;9:R4.
16. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 2000;289:1524-9.
17. Li J, Wang LF, Li ZQ, Pan W. Effect of R219K polymorphism of the ATP-binding cassette transporterA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol. 2009;36:567-70.
18. Hafstrom I, Rohani M, Deneberg S, Wornert M, Jogestrand T, Frostegard J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study. J Rheumatol. 2007;34:1810-6. (Pubitemid 350067638)
19. Gokal R, Mann JI, Moore RA, Morris PJ. Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment. Q J Med. 1979;48:507-17. (Pubitemid 10210774)
20. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.